share_log

AbbVie Shares Are Trading Lower After the Company Announced the Acquisition of Celsius Therapeutics.

Benzinga ·  Jun 28 00:44
AbbVie Shares Are Trading Lower After the Company Announced the Acquisition of Celsius Therapeutics.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment